Kazuya Sakai, Tatsuhiko Someya, Kaori Harada, Hideo Yagi, Taei Matsui and Masanori Matsumoto (2019) “Novel aptamer to von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab”, Haematologica. Pavia, Italy, 105(11), pp. 2631-2638. doi: 10.3324/haematol.2019.235549.